Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ATGen Canada Inc
The NK Vue diagnostic test for natural killer cell activity uses the principle of stimulation of whole blood with a proprietary cytokine followed by the quantitative detection of interferon-gamma using an immunoassay. NK Vue is intended to be used for the monitoring of the immune status of individuals. Measurement of NK cell activity could be a useful tool for assessing changes in immunosurveillance in patients with conditions or diseases where NK cell activity has been shown to be affected.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
1. Male aged ≥ 18 years old
2. Able to read and sign an approved informed consent form
3. Soon to be undergoing a needle prostate biopsy for suspected prostate cancer; patients with a history of prior biopsy are not excluded provided the biopsy was negative
4. All prior and current recorded PSA levels are \< 11 ng/mL (minimum of 2 values must be available)
5. Digital Rectal Exam performed or scheduled to be performed prior to biopsy
You may not be if
1. Any other established malignancy with the exception of basal cell carcinoma
2. At time of blood collection, an active infection (eg bacterial, viral etc.) as declared by the patient
3. Chronic inflammatory condition requiring anti-inflammatory treatment such as rheumatoid arthritis, Crohn's or ulcerative colitis, Lupus or any connective tissue condition which, in the opinion of the investigator, might affect the immune response
4. Presently taking any of the following classes of medications on a regular basis:
* 5-alpha reductase inhibitors
* Anti-inflammatories, with the exception of low dose (81 mg) acetylsalicylic acid
* Anti-androgens
* Testosterone replacement therapy
Clareo Health | Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biopsy
